Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Infect Dis ; 3(1): 34-44, 2017 01 13.
Article in English | MEDLINE | ID: mdl-27798837

ABSTRACT

Plasmodium falciparum (Pf) prolyl-tRNA synthetase (ProRS) is one of the few chemical-genetically validated drug targets for malaria, yet highly selective inhibitors have not been described. In this paper, approximately 40,000 compounds were screened to identify compounds that selectively inhibit PfProRS enzyme activity versus Homo sapiens (Hs) ProRS. X-ray crystallography structures were solved for apo, as well as substrate- and inhibitor-bound forms of PfProRS. We identified two new inhibitors of PfProRS that bind outside the active site. These two allosteric inhibitors showed >100 times specificity for PfProRS compared to HsProRS, demonstrating this class of compounds could overcome the toxicity related to HsProRS inhibition by halofuginone and its analogues. Initial medicinal chemistry was performed on one of the two compounds, guided by the cocrystallography of the compound with PfProRS, and the results can instruct future medicinal chemistry work to optimize these promising new leads for drug development against malaria.


Subject(s)
Amino Acyl-tRNA Synthetases/antagonists & inhibitors , Antimalarials/pharmacology , Enzyme Inhibitors/pharmacology , Plasmodium falciparum/enzymology , Binding Sites , Cloning, Molecular , Drug Discovery , Gene Expression Regulation, Enzymologic/drug effects , Models, Molecular , Plasmodium falciparum/drug effects , Protein Conformation , Small Molecule Libraries
2.
Acta Crystallogr Sect F Struct Biol Cryst Commun ; 67(Pt 9): 998-1005, 2011 Sep 01.
Article in English | MEDLINE | ID: mdl-21904040

ABSTRACT

The recombinant expression of soluble proteins in Escherichia coli continues to be a major bottleneck in structural genomics. The establishment of reliable protocols for the performance of small-scale expression and solubility testing is an essential component of structural genomic pipelines. The SSGCID Protein Production Group at the University of Washington (UW-PPG) has developed a high-throughput screening (HTS) protocol for the measurement of protein recovery from immobilized metal-affinity chromatography (IMAC) which predicts successful purification of hexahistidine-tagged proteins. The protocol is based on manual transfer of samples using multichannel pipettors and 96-well plates and does not depend on the use of robotic platforms. This protocol has been applied to evaluate the expression and solubility of more than 4000 proteins expressed in E. coli. The UW-PPG also screens large-scale preparations for recovery from IMAC prior to purification. Analysis of these results show that our low-cost non-automated approach is a reliable method for the HTS demands typical of large structural genomic projects. This paper provides a detailed description of these protocols and statistical analysis of the SSGCID screening results. The results demonstrate that screening for proteins that yield high recovery after IMAC, both after small-scale and large-scale expression, improves the selection of proteins that can be successfully purified and will yield a crystal structure.


Subject(s)
Chromatography, Affinity/methods , Crystallography, X-Ray , Proteins/isolation & purification , Base Sequence , Molecular Sequence Data , Nickel/chemistry , Protein Binding , Proteins/chemistry , Sequence Alignment
3.
J Struct Funct Genomics ; 11(1): 91-100, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20364333

ABSTRACT

Structural genomics discovery projects require ready access to both X-ray diffraction and NMR spectroscopy which support the collection of experimental data needed to solve large numbers of novel protein structures. The most productive X-ray crystal structure determination laboratories make extensive use of tunable synchrotron X-ray light to solve novel structures by anomalous diffraction methods. This requires that frozen cryo-protected crystals be shipped to large multi acre synchrotron facilities for data collection. In this paper we report on the development and use of the first laboratory-scale synchrotron light source capable of performing many of the state-of-the-art synchrotron applications in X-ray science. This Compact Light Source is a first-in-class device that uses inverse Compton scattering to generate X-rays of sufficient flux, tunable wavelength and beam size to allow high-resolution X-ray diffraction data collection from protein crystals. We report on benchmarking tests of X-ray diffraction data collection with hen egg white lysozyme, and the successful high-resolution X-ray structure determination of the Glycine cleavage system protein H from Mycobacterium tuberculosis using diffraction data collected with the Compact Light Source X-ray beam.


Subject(s)
Proteins/chemistry , X-Ray Diffraction/methods , Amino Acid Oxidoreductases , Carrier Proteins , Glycine Decarboxylase Complex H-Protein , Multienzyme Complexes , Muramidase , Mycobacterium tuberculosis/chemistry , Synchrotrons , Transferases , X-Ray Diffraction/instrumentation , X-Rays
SELECTION OF CITATIONS
SEARCH DETAIL
...